Cargando…
Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor
INTRODUCTION: Peptides can be rationally designed as non-covalent inhibitors for molecularly targeted therapy. However, it remains challenging to efficiently deliver the peptides into the targeted cells, which often severely affects their therapeutic efficiency. METHODS: Herein, we created a novel n...
Autores principales: | Sui, Min, Xiong, Meimei, Li, Yuling, Zhou, Qiao, Shen, Xiaofei, Jia, Da, Gou, Maling, Sun, Qingxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054660/ https://www.ncbi.nlm.nih.gov/pubmed/33883894 http://dx.doi.org/10.2147/IJN.S266398 |
Ejemplares similares
-
Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals
por: Li, Yuling, et al.
Publicado: (2019) -
CRM1 Inhibitors for Antiviral Therapy
por: Mathew, Cynthia, et al.
Publicado: (2017) -
Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020) -
Targeted nanoparticle-mediated LHPP for melanoma treatment
por: Zhang, Qianqian, et al.
Publicado: (2019) -
CRM for dummies
por: Helgeson, Lars
Publicado: (2017)